The invasive, large cell, non-keratinizing CERV-215 cell line was established in vitro from the xenotransplant cervix carcinoma MRI-H-215 by Cell Lines Service. Primary xenotransplant adopted to in vivo transplantation by Dr. Bodgen, Mason Research Institute.